At the February 2015 ACIP meeting held last month, recommendations were made for meningococcal, influenza, and HPV vaccines. The updated recommendations for meningococcal and HPV vaccines were particularly important, as they each come with unique challenges.
You may have missed the recent webinars hosted by NFID, discussing how to overcome these challenges, but archived versions of the webinars are available online at www.nfid.org/webinars:
The Role of New Serogroup B Vaccines in Preventing Meningitis Outbreaks: NFID experts, Carol J. Baker, MD, Lorry G. Rubin, MD, and William Schaffner, MD, discuss unique challenges of meningococcal disease, new ACIP recommendations for serogroup B vaccine use, and considerations for future recommendations.
Five Key Steps to Improve HPV Vaccination Rates in Your Practice: Joseph A. Bocchini, Jr., MD and Noel T. Brewer, PhD discuss HPV vaccination barriers and opportunities and will present five key steps that healthcare professionals (HCPs) can take to improve HPV vaccination rates in their practices, based on the NFID Call to Action, HPV Vaccination as a Public Health Priority.
Related Posts
Protecting the Health of Black Children
Failure to understand the history of vaccine-preventable diseases risks dooming US children to again suffer needlessly from preventable infections
Advancing Prevention in a Complex Respiratory Season
2025–2026 Respiratory Campaign round-up: NFID and partners urge immunization to help protect against COVID-19, flu, RSV, and pneumococcal disease
There’s Nothing New About Applying a ‘Gold Standard’ to Vaccine Trials
How vaccine clinical trials work—and the true “gold standard” for safety, effectiveness, and ethics
